Trial Profile

Pilot trial of amlodipine/celecoxib [KIT-302] in patients with hypertension

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine/celecoxib (Primary) ; Amlodipine; Celecoxib
Indications Hypertension
Focus Pharmacokinetics

Most Recent Events

10 May 2016 According to Kitov media release, company will submit NDA to the FDA at the end of this year and anticipated marketing approval in 2017. Results from this study has fulfilled the FDA standard for demonstrating bioequivalence under both fed and fasted conditions.
10 May 2016 Results published in Kitov media release.
10 May 2016 Status changed from planning to completed, as per Kitov media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com